StrokeNUAGENCT07805694
Neurovascular Unit for Aged Patients With Geriatric Care and Evaluation of Factors Associated With Autonomy Loss
An observational study of Stroke, run by Hospices Civils de Lyon at 1 site in France.
Trial summary
There are few neurovascular units (short stay and MRS (medical and rehabilitation service)) dedicated to the care of older people after a stroke in France and around the world. The geriatric medicine department at Charpennes Hospital developed this unit more than 20 years ago, giving it unique experience and expertise… Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Stroke
- What is being tested?
- Not applicable- observational study
- How many people
- 3,500 participants
- Where
- 1 siteFrance
- Study dates
- 15 Dec 2026to 31 Dec 2031
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: Patients over 65 years of age hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for the elderly (4AC) at Charpennes Hospital, HCL Villeurbanne
Who may be able to join
- - Patients over 65 years of age
- Hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for the elderly (4AC) at Charpennes Hospital, HCL Villeurbanne
Who cannot join
- - Patients, relatives/trusted individuals, legal representatives who object to the research
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site
Hôpital des Charpennes (Hospices Civils de Lyon)
Villeurbanne, 69100
About this study
There are few neurovascular units (short stay and MRS (medical and rehabilitation service)) dedicated to the care of older people after a stroke in France and around the world. The geriatric medicine department at Charpennes Hospital developed this unit more than 20 years ago, giving it unique experience and expertise acquired over many years. However, to date, the profiles of patients included in these units and the factors associated with loss of independence and the outcomes of older patients hospitalized in neurovascular units for older adults remain unknown. In this context, the NUAGE study aims to describe the population cared for in this unit and analyze the factors associated with patient outcomes.
- Conditions
- Stroke
- Being tested
- Not applicable- observational study
- Keywords
- Neurovascular hospital unit, Comorbidities, Autonomy
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Not applicable- observational studyOther
not applicable - observational study
| Study group | Role | What they receive |
|---|---|---|
| Patients hospitalized in the neurovascular unit for older adults at Charpennes Hospital, HCL. | Patients over 65 years of age hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for older adults at Charpennes Hospital, HCL Villeurbanne Receives: Other: Not applicable- observational study |
What is being measured
The primary outcome is the main question the study is designed to answer.
Describe the characteristics of hospitalized patients and their outcomes in the geriatric neurovascular unit at Hôpital des Charpennes (short stay and MRS).
The following data will be collected to describe the characteristics of the study population :
Age (years) Gender (F/M) IMC (kg/m²) Smoking/alcohol consumption Comorbidities (Charlson score) Presence/Absence of Hypertension, DiabetesTreatment Type of stroke (ischemic or hemorrhagic) + Artery involved Complications related to treatment (falls, spastic pain, swallowing disorders, malnutrition, infections, bedsores, epilepsy) Biological parameters (cholesterol (g/L), albumin (g/L)) Cognitive and cardiovascular assessments related to stroke assessment (cardiac ultrasound, arterial Doppler ultrasound, radiocinema) National Institutes of Health Stroke Scale (NIHSS) Modified Rankin Scale (mRS) Measure of functional independence (MIF) Type of discharge (death, institutionalization, return home)
Measured: Data will be collected on the day of admission (day 1 of the patient's hospitalization) and on the day of his/her discharge from the neurovascular unit.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Sep 2026
- Study start15 Dec 2026 (estimated)
- Primary completion31 Dec 2030 (estimated)
- Study completion31 Dec 2031 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- More trials run by Hospices Civils de LyonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 3,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospices Civils de Lyon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07805694
- Sponsor's protocol ID
- 25-5376
- Acronym
- NUAGE
- Status last verified
- Jun 2026
- First submitted
- 11 Jun 2026
- Last updated
- 4 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 4 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Neurovascular Unit for Aged Patients With Geriatric Care and Evaluation of Factors Associated With Autonomy Loss
- ClinicalTrials.gov ID
- NCT07805694
- Acronym / sponsor ID
- NUAGE / 25-5376
- Conditions
- Stroke
- Keywords
- Neurovascular hospital unit, Comorbidities, Autonomy
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 3,500 participants (estimated)
- Lead sponsor
- Hospices Civils de LyonUniversity, hospital or other
- Study start
- 15 Dec 2026 (estimated)
- Primary completion
- 31 Dec 2030 (estimated)
- Study completion
- 31 Dec 2031 (estimated)
- First posted
- 4 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
There are few neurovascular units (short stay and MRS (medical and rehabilitation service)) dedicated to the care of older people after a stroke in France and around the world. The geriatric medicine department at Charpennes Hospital developed this unit more than 20 years ago, giving it unique experience and expertise acquired over many years. However, to date, the profiles of patients included in these units and the factors associated with loss of independence and the outcomes of older patients hospitalized in neurovascular units for older adults remain unknown. In this context, the NUAGE study aims to describe the population cared for in this unit and analyze the factors associated with patient outcomes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients hospitalized in the neurovascular unit for older adults at Charpennes Hospital, HCL. | – | Other: Not applicable- observational studyPatients over 65 years of age hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for older adults at Charpennes Hospital, HCL Villeurbanne |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- Patients over 65 years of age hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for the elderly (4AC) at Charpennes Hospital, HCL Villeurbanne
Key inclusion criteria (2 listed)
- - Patients over 65 years of age
- Hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for the elderly (4AC) at Charpennes Hospital, HCL Villeurbanne
Key exclusion criteria (1 listed)
- - Patients, relatives/trusted individuals, legal representatives who object to the research
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Not applicable- observational studynot applicable - observational study | Other | Patients hospitalized in the neurovascular unit for older adults at Charpennes Hospital, HCL. |
Primary outcome
Describe the characteristics of hospitalized patients and their outcomes in the geriatric neurovascular unit at Hôpital des Charpennes (short stay and MRS).
Time frame: Data will be collected on the day of admission (day 1 of the patient's hospitalization) and on the day of his/her discharge from the neurovascular unit.
The following data will be collected to describe the characteristics of the study population : Age (years) Gender (F/M) IMC (kg/m²) Smoking/alcohol consumption Comorbidities (Charlson score) Presence/Absence of Hypertension, DiabetesTreatment Type of stroke (ischemic or hemorrhagic) + Artery involved Complications related to treatment (falls, spastic pain, swallowing disorders, malnutrition, infections, bedsores, epilepsy) Biological parameters (cholesterol (g/L), albumin (g/L)) Cognitive and cardiovascular assessments related to stroke assessment (cardiac ultrasound, arterial Doppler ultrasound, radiocinema) National Institutes of Health Stroke Scale (NIHSS) Modified Rankin Scale (mRS) Measure of functional independence (MIF) Type of discharge (death, institutionalization, return home)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Sep 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Stroke, run by Hospices Civils de Lyon at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Marie M BRETON, MD (04.72.43.21.18 ext. 0033, marie.breton@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Describe the characteristics of hospitalized patients and their outcomes in the geriatric neurovascular unit at Hôpital des Charpennes (short stay and MRS). (time frame: Data will be collected on the day of admission (day 1 of the patient's hospitalization) and on the day of his/her discharge from the neurovascular unit.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2026.